A lack of strategic marketing can keep a covered entity from fulfilling its mission. Avita’s Glen Pietrandoni & Liz Eckert offer five tips for engaging patients.

Alleviating the massive health equity crisis will take innovative thinking from across the industry. Avita’s Michael Yount and Dr. Joel Rosenstock discuss why.

At the 340B Coalition Summer Conference, Avita Board Member Dr. Jerome Adams offered advice on supporting the drug discount program’s future. Read on for insights from 340B Report.

The landscape for covered entities is changing quickly, and both the future of your business and the wellness of your patients is on the line.